Skip to main content
Tanium logo

Tanium

Security and trust center evidence

tanium.comDevOps and observabilityLast verified 17 Sep 2026

Summary

Tanium has 3 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 17 Sep 2026, Tanium is listed in the FedRAMP registry as FedRAMP Authorized, with the authorization issued 8 Nov 2023 and audited by Lunarline, Inc. As of 17 Sep 2026, Tanium is listed in the CSA STAR registry at Level 1 self-assessment (CAIQ), issued 13 Jul 2021. As of 17 Sep 2026, Tanium is listed in the EU-US Data Privacy Framework registry as Active, covering the UK Extension Certification, Swiss-US Certification, and EU-US Certification, issued 12 Jun 2019 and expiring 11 Aug 2027. As of 17 Sep 2026, no public evidence found for SOC 2 for Tanium. As of 17 Sep 2026, no public evidence found for HIPAA for Tanium.

  • FedRAMP: listed in FedRAMP registry as FedRAMP Authorized (issued 8 Nov 2023, auditor Lunarline, Inc.) — as of 17 Sep 2026.
  • CSA STAR: listed in CSA STAR registry at Level 1 self-assessment (CAIQ), issued 13 Jul 2021 — as of 17 Sep 2026.
  • EU-US Data Privacy Framework: listed in DPF registry as Active (EU-US, Swiss-US, UK Extension), issued 12 Jun 2019, expires 11 Aug 2027 — as of 17 Sep 2026.

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.

Among devops and observability vendors

3verified rows

Category median 1, across 90 indexed devops and observability vendors. Tanium has more verified rows than 100 percent of them.

endpoint managementit operationssecurityvisibility

Compliance grid

Subprocessors

No subprocessor list captured yet.

Similar vendors with evidence

Related by product tags and the DevOps and observability category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.